Monthly Archives: November 2011

The Power of Network Marketing – by David Wood

Mark Yarnell was a minister in a small town in Texas. Unfortunately, he was headed for bankruptcy and was just about to lose his car and home. He was looking for a way out and discovered network marketing. Luckily, he had a wise sponsor.

His sponsor gave Mark what he called “THE PRICE OF PROMISE”. The promise is: “This business can set you free financially in one to three years.” The price is: “To succeed, you will have to face and conquer 4 major enemies. “Mark said, “It’s a deal.”

Mark began by inviting 200 friends over to his house to watch a video. 80 said “No, not interested”

Mark had encountered ENEMY #1: Rejection.
He thought, “No problem. My sponsor warned me about that. But I still have 120 people
that are confirmed to come over.” Guess what? Only 70 showed up.

Mark had just encountered ENEMY #2: Deception.
Mark thought, “No problem. My sponsor warned me about that. At least those 70 people
watched the video!” Guess what? 57 said “Not Interested”.

Mark had just encountered ENEMY #3: Apathy.
Undaunted, Mark thought, “No problem – 13 people DID sign up!” Guess what? 12 of them
dropped out of the business shortly thereafter.

Mark had just encountered ENEMY #4: Attrition.
Attrition had left Mark with just one serious associate. Guess what? To this day, that single
distributor earns Mark over $50,000 per month.

Mark Yarnell’s story is NOT Unique!

You may have heard of Bill Britt, one of the most successful distributors in Amway. Some
years ago, 20/20 did a feature story on Amway. The story spent 19 minutes interviewing
whiners and complainers – distributors who had failed. They showed garages full of
products they couldn’t sell. During the last minute of the show, Mr. Britt was interviewed in
front of his palatial home. He was asked, “Mr. Britt, this business has obviously worked for
you. What’s your secret?”

He replied, “There is no secret. I simply showed the plan to 1200 people. 900 said, ‘No’ and
only 300 signed up. Out of those 300, only 85 did anything at all. Out of those 85 only 35
were serious, and out of those 35, 11 made me a millionaire.”

Like Mark Yarnell, Bill worked through the numbers.

Jason Boreyko, co-founder of New Vision, told this story. When he was a distributor in
Matol, he signed up 50 people. He heard a lot of “No’s” on the way to those 50. Jason took
one man, who he knew would be terrific in the business, to lunch and told him about the
business. The man said “No”. Jason took the man to lunch again the next month and gave
him some updates. Once again the man said, “No”. Jason sent him some more information
and took him to lunch again the next month. Again the man said, “No”. That went on for six
months. The seventh month, something had changed for the man, and he said, “Yes”. That
man made Jason over one million dollars. Jason also worked through his numbers.

While starting Amway, Rich DeVos and Jay Van Andel, America’s eleventh richest entity,
recruited 500 people. 495 dropped out. The five that didn’t quit, built Amway. All $7 billion
of Amway’s business was built under those 5 people. Jay and Rich had to work through the

There are many similar stories.

Jeff, the top money earner in Mannatech, signed up 27 people his first month. One might
think that he is especially talented at sponsoring. Actually, Jeff will be the first to tell you
that he is not talented at all. In fact, he feels that he did very poorly. To recruit those 27, Jeff
talked to 2000 people that first month. And of the 27, the only one who did anything
significant with the business was Ray Gebauer, who has more than half of Mannatech in his
downline. Jeff’s word to you is this: The numbers never lie. Pick your goal and then get
into massive action. If you talk to enough people, you will make it!

Here’s the lesson: Your success is directly related to the degree to which you are willing to
work to find others like yourself who are committed to succeed. Mark Yarnell’s odds were
1 in 50. Jeff’s were really 1 in 2000. Would you be willing to go through 200 people to find
the 1 who will make you $50,000 a month? Or go through 200 people to become a
millionaire? Or hear “No” uncounted times to sign up 50 people and find that million dollar
person? I hope you will. It’s easier when you know the odds up front.

But here’s the catch: You have your own set of odds – and you won’t know what they are

So if you’ve gone through 50 or 100 people and you haven’t found 1 serious person yet, you
can either give up and assume the business doesn’t work, or recognize that you are
working through your own numbers.

Are you willing to find out what your own set of odds is?

This means that you must pay the price for freedom. Remember that the numbers never
fail you. Despite where your skill level is, your success is assured if you talk to enough
people. And as your skill improves, so will your odds.

There is no such thing as luck in this industry. Winning big is a matter of being willing to
pay the price. Are you willing? Your future is in your hands! The choices which you make
today will determine the course of your entire future.


RYL’s Beta Glucan Researched by Prestigious Universities

Beta Glucan has been researched and documented by some of the most prestigious universities in the world:

  • Auburn University

  • Brown University

  • Cornell University

  • Memorial Sloan Kettering Cancer Center

  • North Carolina A & T State University

  • University of Louisville

  • University of Massachusetts

  • University of Minnesota

  • U.S. Armed Forces Radiobiology Research Institute

  • Defense Research Establishment in Suffield, Cananda

“As it is a natural substance, there are no side effects and there is no danger of overdose. Clearly Beta glucan is a natural, safe, specific, and highly effective way to keep our immune system healthy.” – Dr. Vaclav Vetvicka, University of Lousiville


The Common Cold, Flu and Beta Glucan

The common cold, typically caused by human parainfluenza viruses, remains one of the most frustrating of medical illnesses, given its incidence and prevalence.  The common cold has significant effects on health, well-being, and productivity.  Each cold experienced by a working adult results in an average of 8.7 lost work hours, and 1.2 lost work hours due to attending to sick children.1  The economic burden of lost productivity due to colds is approximately $25 billion annually, with lost productivity from missed work days comprising the majority of the financial burden.2   There are no reliable interventions currently available that significantly protect against influenza infections or prevent the occurrence of this illness.  There have been several clinical trials evaluating a variety of dietary supplements for the prevention and treatment of both experimentally induced and naturally occurring colds. Biological response modifiers such as beta-glucan, enhance the innate immune response without inducing damaging pro-inflammatory cytokines, and may represent a novel approach to protect against cold and flu pathogens.3

Beta-glucans are glucose polymers derived from yeast, fungi, or from oats.  In vivostudies suggest beta-glucans may enhance the immune system responses to infectious organisms without eliciting a pro-inflammatory cytokine response.3,4-8

In clinical trials, beta-glucan reduces postoperative infection rates and shortens intensive care unit stay duration.9-11   One study also reported that increasing doses of beta-glucan resulted in fewer infections after surgery.9

Beta-glucan appears to improve immune function in a variety of animal models, without increasing pro-inflammatory cytokines or inducing a febrile response.3,7,12,13

It appears that beta-glucan may be a powerful immune stimulator, as evidenced by its ability to activate macrophages and stimulate positive immune actions on B lymphocytes, natural killer cells, and suppressor T cells in the immune system.14-16   Many in vitro studies have shown that beta-glucan significantly increases microbiocidal activity of human neutrophils and macrophages against a variety of pathogens without directly stimulating synthesis of the cytokines, IL-1 or TNF.  The exact pathway through which beta-glucans interact with the immune system is unknown.  One proposed mechanism is the activation of Dectin-1 pattern recognition receptor on blood peripheral mononuclear cells.17,18

Literature Cited:

  1. Bramley TJ, Lerner D, Sames M.  Productivity losses related to the common cold.  J Occup Environ Med 2002;44(9):822-9.
  2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.  The annual impact of seasonal influenza in the US:  measuring disease burden and costs.  Vaccine 2007;25(27):5086-96
  3. Niederman R, Kelderman H, Socransky S, Ostroff G, Genco C, Dent R, Jr., Stashenko P.  Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following beta-glucan treatment of mice.  Arch Oral Biol 2002;47(8):613-8.
  4. Bedirli A, Kerem M, Pasaoglu H, Akyurek N, Tezcaner T, Elbeg S, Memis L, Sakrak O.  Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis.  Shock 2007;27(4):397-401.
  5. Ikewaki N, Fujii N, Onaka T, Ikewaki S, Inoko H.  Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement.  Microbiol Immunol 2007;51(9):861-73.
  6. Liang J, Melican D, Cafro L, Palace G, Fisette L, Armstrong R, Patchen ML.  Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with beta-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity.  Int J Immunopharmacol 1998;20(11):595-614.
  7. Onderdonk AB, Cisneros RL, Hinkson P, Ostroff G.  Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.  Infect Immun 1992;60(4):1642-7.
  8. Kaiser AB, Kernodle DS.  Synergism between poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model.  Antimicrob Agents Chemother 1998:42(9):2449-51.
  9. Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P.  A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (beta-glucan) in high-risk surgical patients.  Arch Surg 1994;129(11):1204-10.
  10. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA.  Randomized phase I/II trial of a macrophage-specific immunomodulator (beta-glucan) in high-risk surgical patients.  Ann Surg 1994;220(5):601-9.
  11. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE.  Effect of beta-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations.  Betafectin Gastrointestinal Study Group.  Arch Surg 1999;134(9):977-83.
  12. Sandvik A, Wang YY, Morton HC, Aasen AO, Wang JE, Johansen FE.  Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats.  Clin Exp Immunol 2007;48(1):168-77.
  13. Kournikakis B, Mandeville R, Brousseau P, Ostroff G.  Anthrax-protective effects of yeast beta 1,3 glucans.  MedGenMed 2003;5(1):1.
  14. Brown GD, Gordon S.  Immune recognition of fungal beta-glucans.  Cell Microbiol 2005;7(4):471-9.
  15. Castro GR, Ranilaitis B, Bora E, Kaplan DL.  Controlled release biopolymers for enhancing the immune response.  Mol Pharm 2007;4(1):33-46.
  16. Rice PJ, Adams EL, Ozment-Skelton T, Gonzalez AJ, Goldman MP, Lockhart BE, Barker LA, Breuel KF, Depont WK, Kalbfleisch JH, Ensley HE, Brown GD, Gordon S, Williams DL.  Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge.  J Pharmacol Exp Ther 2005;314(3):1079-86.
  17. Nerren JR, Kogut MH.  The selective Dectin-1 agonist, curdlan, induces an oxidative burst response in chicken heterophils and peripheral blood mononuclear.  Vet Immunol Immunopathol 2009 Jan 15;127(1-2):162-6.  Epub 2008 Sep
  18.  Shah VB, Huang Y, Keshwara R, Oxment-Skelton T, Williams DL, Keshvara L.  Beta-glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner.  J Immunol 2008 Mar 1;180(5):2777-85.

The United States Pharmacopeial Convention

The United States Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the quality, purity, identity, and strength of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are developed and relied upon in more than 130 countries. These standards have helped ensure public health throughout the world for close to 200 years.

The United States Pharmacopeia (USP) has developed the first official monograph for beta glucan from bakers yeast (Saccharomyces Cerevisiae), a natural food, beverage and dietary supplement ingredient widely recognized for its immune health benefits.  The monograph was recently issued in the Third Supplement of the Seventh Edition of the Food Chemicals Codex, an internationally recognized compendium of standards for the purity and identity of food ingredients.

The USP Expert Committee approved the proposed monographs after being published in Pharmacopeial Forum for public comment. USP sets standards for manufacturers to comply for products legally marketed in the U.S. These monographs address quality, identification, labeling, purity, and potency, among other tests. All beta glucans from baker’s yeast must fulfill the requirements of the USP monographs, at a minimum. The monographs will facilitate FDA’s determination of compliance of the marketed products to these public standards.

“The beta glucan in all your products are manufactured and tested under the guidelines accepted and set by the USP.  It is doubtful that other yeast beta glucan products marketed here in the US comply with these standards.” (In the opinion of AJ Lanigan)


Great Information: Beta Glucan Research Paper

Health Benefits of Beta Glucan

According to a newly published research article Beta Glucan is MAKING THE NEWS!

It shows the safety and health benefits of Beta Glucan when used with food products.

Here are some of the recognized Health Benefits from the article—

Beta glucan provides numerous beneficial health effects such as:

  • Reduced bowel transit time (Feldheim & Wisker, 2000),
  • Prevention of constipation,
  • Reduced risk of colorectal cancer(Bingham, 1990; Faivre & Bonithin Kopp, 1999; Hill, 1997),
  • Lower blood cholesterol,
  • Better regulated blood glucose levels (Bornet et al., 1987; Frost et al., 1999; Gallagher et al., 1993;German et al., 1996),
  • Production of short chain fatty acids (Karppinen et al., 2000; Velasquez etal., 2000; Wisker et al., 2000),
  • Promotion of the growth of the beneficial bacteria in the colon and improved digestion(Crittenden et al., 2002; Tugland, 2003)
  • Contributes to the intestinal viscosity and thereby Reduces Cholesterol Absorption (Bernardshaw etal., 2006).
  • Studies on beta glucan have shown that it is a promising substance in promoting many health benefits in humans, and further investigation of developing novel products containing betaglucan is suggested.
  • United States Food and Drug Administration (FDA) permits products containing beta glucan to make health claims related to lower cholesterol and minimize risk of coronary heart diseases (CHD).
  • To meet the daily dietary intake levels, one serving of the product containing 3g of beta glucan is necessary to make the health claims on the product.

Resveratrol–An Important Ingredient in ReStart Your Life’s Beta Glucan RVB 300

An Important Ingredient
in ReStart Your Life’s
Beta Glucan RVB 300

RVB300 (Beta 1,3-D Glucan & Resveratrol mix)*Patent Protected

 “The biologically most relevant immunomodulator*” just got better!

A standardized, proprietary blend of Beta 1, 3-D Glucan, Resveratrol and Vitamin C that provides the most studied and proven immune supplement support for your everyday immune system needs.

RVB 300 contains–

  • 100 mg. Beta 1, 3-D Glucan

  • 100 mg. Resveratrol

  • 50 mg. Vitamin C

According to the  British Journal of Nutrition April 21, 2011—-

  • Resveratrol at a dosage of 10mg per day is associated with reduction of insulin resistance in type-2 diabetics

Other studies with  resveratrol have reported–

  • anti-cancer effects,

  • anti-inflammatory effects,

  • cardiovascular benefits,

  • anti-diabetes potential,

  • energy endurance enhancement, and

  • protection against Alzheimer’s

%d bloggers like this: